Harmonization in pharmacovigilance in 2026

Regulatory safety experts reviewing global data to support regulatory harmonization, safety reporting consistency, and post-marketing safety oversight in multinational pharmacovigilance operations.

Inspection trends show that inconsistent global safety practices remain a leading source of pharmacovigilance findings. This article explains how regulatory harmonization, aligned safety reporting, and coordinated oversight shape inspection outcomes and support compliant international pharmacovigilance operations.